Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Coraspirina 81 mg Tabletas Con Cubierta Enterica

Last content change checked dailysee data sync status

Active ingredient
Aspirin 81 mg
Other brand names
Dosage form
Tablet, Coated
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2001
Label revision date
January 17, 2025
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Aspirin 81 mg
Other brand names
Dosage form
Tablet, Coated
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2001
Label revision date
January 17, 2025
Manufacturer
Bayer HealthCare LLC.
NDC root
0280-2055
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Corespirina 81 mg is a medication that is commonly used for its beneficial effects on heart health. While the specific uses are not detailed in the provided information, medications like Corespirina are often utilized to help reduce the risk of heart attacks and strokes by improving blood flow and preventing blood clots.

This medication is presented in a packaging that includes an image reference, making it easier for you to identify. If you have any questions about how Corespirina 81 mg may be appropriate for your health needs, it's always best to consult with a healthcare professional.

Uses

Corespirina 81 mg is used to help prevent serious heart-related events if you have a history of heart issues, such as a heart attack (myocardial infarction), unstable angina, or other types of coronary artery disease. Additionally, it can reduce the risk of stroke for those who have experienced transient ischemic attacks (temporary episodes of stroke-like symptoms) or ischemic strokes (strokes caused by blocked blood flow to the brain).

By taking Corespirina, you are taking an important step in managing your cardiovascular health and reducing the likelihood of future complications. Always consult with your healthcare provider to ensure this medication is right for you.

Dosage and Administration

You will take this medication by mouth, which means you will swallow it rather than using it in any other way, such as through an injection. Each dose contains 81 mg of aspirin, which is the active ingredient that helps with various health issues, including pain relief and reducing inflammation.

Make sure to follow your healthcare provider's instructions on how often to take this medication. It's important to take it consistently as directed to achieve the best results for your health. If you have any questions about your dosage or how to take it, don’t hesitate to reach out to your doctor or pharmacist for guidance.

What to Avoid

It seems that the information regarding what to avoid while using this medication is not specified in the provided text. Therefore, I cannot provide specific contraindications, controlled substance details, or instructions on abuse, misuse, or dependence.

If you have any other questions or need information on a different topic, feel free to ask!

Side Effects

You may experience a range of side effects while using this medication. Common gastrointestinal issues include abdominal pain, nausea, vomiting, and diarrhea, as well as more serious concerns like gastrointestinal bleeding and ulceration. There is also a risk of bleeding and a condition called thrombocytopenia (low platelet count). Allergic reactions can occur, including severe ones like anaphylaxis (a life-threatening allergic reaction), angioedema (swelling beneath the skin), and urticaria (hives).

Other potential side effects include acute kidney injury, elevated liver enzymes, tinnitus (ringing in the ears), headaches, rashes, and itching. Additionally, there is an increased risk of cardiovascular events, such as heart attacks and strokes, and respiratory distress may occur. It's important to note the boxed warning regarding the risk of serious gastrointestinal bleeding and ulceration, especially if you have a history of peptic ulcer disease or gastrointestinal bleeding. If you notice any severe reactions, seek medical attention promptly.

Warnings and Precautions

It seems that the specific warnings, precautions, and instructions for emergency help or stopping use of the medication were not provided in the text. Therefore, I cannot offer detailed information on these important aspects.

If you have any specific concerns or questions about a medication, it's best to consult your healthcare provider or pharmacist. They can provide you with the necessary information tailored to your situation. Always prioritize your health and safety by seeking professional advice when needed.

Overdose

If you suspect an overdose, it’s crucial to seek immediate medical attention. Signs of an overdose can include nausea, vomiting, abdominal pain, and ringing in the ears (tinnitus). In more severe cases, it may lead to serious conditions such as metabolic acidosis (an imbalance in the body's acid-base levels), respiratory alkalosis (a disturbance in the body's carbon dioxide levels), and kidney failure.

Treatment for an overdose typically involves supportive care, which means helping to manage symptoms and providing necessary medical support. Always prioritize your health and safety by contacting a healthcare professional if you experience any of these symptoms or if you believe an overdose has occurred.

Pregnancy Use

It’s important to be cautious with medications during pregnancy. Coraspirina (aspirin) is not recommended for use, especially in the third trimester, as it can pose risks to your developing baby. Using aspirin while pregnant may lead to complications for the fetus, so it should only be taken if your healthcare provider believes the benefits outweigh the potential risks.

If you are pregnant or planning to become pregnant, always consult with your doctor before taking any medication, including over-the-counter drugs like aspirin. Your health and the health of your baby are the top priority, so make sure to discuss any concerns or questions you may have.

Lactation Use

When it comes to breastfeeding, it's important to be aware that there are no specific guidelines or statements regarding nursing mothers or lactation (the process of producing milk). This means that if you are breastfeeding, you may not find detailed information about how certain medications or treatments could affect you or your baby.

If you have concerns about breastfeeding while taking any medication, it's always best to consult with your healthcare provider for personalized advice and to ensure the safety of both you and your infant.

Pediatric Use

When considering this product for your child, it's important to know that its safety and effectiveness in children have not been established. This means that there hasn't been enough research to confirm whether it is safe or works well for pediatric patients (children and adolescents). Therefore, you should consult with your child's healthcare provider before using this product to ensure it is appropriate for their specific needs.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment plan.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (liver issues).

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that you receive the safest and most effective treatment based on your individual needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that this medication is generally considered safe to use with other drugs and tests. However, every individual is different, and your healthcare provider can help ensure that your treatment plan is safe and effective for you.

Always remember that discussing your full list of medications and any lab tests with your healthcare provider is crucial. This way, you can avoid any potential issues and receive the best care tailored to your needs.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 20°C and 25°C (68°F to 77°F). It’s acceptable for the temperature to occasionally range from 15°C to 30°C (59°F to 86°F), but try to keep it within the ideal range. Make sure to protect the product from light and always keep the container tightly closed when not in use to maintain its integrity.

When handling the product, be mindful of these storage conditions to ensure safety and effectiveness. Proper storage and handling will help you get the most out of your device.

Additional Information

No further information is available.

FAQ

What is Corespirina 81 mg used for?

Corespirina 81 mg is indicated for the prevention of cardiovascular events in patients with a history of myocardial infarction, unstable angina, or coronary artery disease, and for reducing the risk of stroke in patients with a history of transient ischemic attacks or ischemic stroke.

How should I take Corespirina 81 mg?

You should take one tablet orally once daily, or as directed by your healthcare professional.

What are the possible side effects of Corespirina 81 mg?

Possible side effects include gastrointestinal issues like abdominal pain and nausea, allergic reactions such as anaphylaxis, and increased risk of cardiovascular events. Serious side effects may include gastrointestinal bleeding and ulceration.

Is Corespirina 81 mg safe to use during pregnancy?

Corespirina is contraindicated in pregnancy, especially during the third trimester, as it may pose risks to the fetus.

What should I do if I experience severe allergic reactions while taking Corespirina 81 mg?

If you experience severe allergic reactions, such as anaphylaxis or angioedema, seek emergency medical help immediately.

How should I store Corespirina 81 mg?

Store Corespirina at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Protect it from light and keep the container tightly closed.

Packaging Info

Below are the non-prescription pack sizes of Coraspirina 81 mg Tabletas Con Cubierta Enterica (coraspirin 81 mg enteric coasted tablet). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Coraspirina 81 mg Tabletas Con Cubierta Enterica.
Details

Drug Information (PDF)

This file contains official product information for Coraspirina 81 mg Tabletas Con Cubierta Enterica, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Corespirina is a pharmaceutical formulation containing 81 mg of the active ingredient. It is presented in a dosage form suitable for oral administration. The product is characterized by its specific molecular weight and chemical properties, which are essential for its intended therapeutic use.

Uses and Indications

Corespirina 81 mg is indicated for the prevention of cardiovascular events in patients with a history of myocardial infarction, unstable angina, or other forms of coronary artery disease. Additionally, it is indicated for the reduction of the risk of stroke in patients with a history of transient ischemic attacks or ischemic stroke.

There are no specific teratogenic or nonteratogenic effects associated with Corespirina 81 mg as per the available data.

Dosage and Administration

Aspirin is administered orally at a dosage of 81 mg. The recommended dosing frequency is once daily. Healthcare professionals should ensure that patients are advised to take the medication with a full glass of water to facilitate swallowing and enhance absorption. It is important to instruct patients to take aspirin with food or milk to minimize gastrointestinal irritation.

Monitoring for efficacy and potential side effects is advised, and adjustments to the regimen should be made based on individual patient response and clinical judgment.

Contraindications

There are no specified contraindications for the use of this product. Healthcare professionals should exercise clinical judgment and consider individual patient circumstances when determining the appropriateness of use.

Warnings and Precautions

Healthcare professionals should be aware of the following critical warnings and precautions associated with the use of this medication.

It is essential to monitor patients closely for any adverse reactions or complications that may arise during treatment. Regular laboratory tests may be necessary to assess the patient's response to therapy and to ensure safety. Specific monitoring parameters should be established based on the individual patient's health status and the medication's profile.

In the event of severe side effects or unexpected reactions, immediate medical attention should be sought. Healthcare providers should instruct patients to discontinue use and contact their physician if they experience any concerning symptoms.

Overall, a thorough understanding of the potential risks and the implementation of appropriate monitoring strategies are vital for the safe administration of this medication.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious adverse reactions include a boxed warning for the risk of serious gastrointestinal bleeding and ulceration, particularly in individuals with a history of peptic ulcer disease or gastrointestinal bleeding.

Common gastrointestinal adverse reactions reported include abdominal pain, nausea, vomiting, dyspepsia, heartburn, and diarrhea. More severe gastrointestinal events such as gastrointestinal bleeding and ulceration have also been observed.

Hematologic reactions may manifest as bleeding and thrombocytopenia. Allergic reactions can occur, including anaphylaxis, angioedema, urticaria, and exacerbation of asthma. Renal adverse reactions include acute kidney injury, while hepatic reactions may present as elevated liver enzymes.

Neurological adverse reactions reported include tinnitus and headache. Dermatologic reactions such as rash and pruritus have also been noted. Cardiovascular risks include an increased likelihood of cardiovascular events, such as myocardial infarction and stroke. Respiratory adverse reactions may present as respiratory distress.

In postmarketing experience, severe allergic reactions and Reye's syndrome have been reported, particularly in children and teenagers with viral infections. It is important for healthcare providers to monitor patients for these adverse reactions and manage them appropriately.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Coraspirina 81 mg Tabletas Con Cubierta Enterica (coraspirin 81 mg enteric coasted tablet). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Coraspirina 81 mg Tabletas Con Cubierta Enterica.
Details

Pediatric Use

Pediatric use of this product has not been established. Safety and effectiveness in pediatric patients remain unverified, and therefore, caution is advised when considering this product for use in children, infants, or adolescents.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Coraspirina is contraindicated in pregnancy, particularly during the third trimester. The use of aspirin during pregnancy may pose risks to the fetus, including potential complications. Therefore, aspirin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Healthcare professionals are advised to carefully consider the risks and benefits before prescribing this medication to pregnant patients.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or its effects during lactation. Additionally, there is no available data on the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the absence of information when advising lactating mothers about the use of this medication.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative that the patient seeks immediate medical attention. Prompt intervention is crucial to mitigate potential complications.

Symptoms of Overdose Patients experiencing an overdose may present with a range of symptoms, including nausea, vomiting, abdominal pain, and tinnitus. These symptoms can vary in severity and may indicate the need for urgent medical evaluation.

Severe Complications In more severe cases, overdose can lead to serious complications such as metabolic acidosis, respiratory alkalosis, and renal failure. These conditions require immediate medical assessment and intervention to prevent further deterioration of the patient's health.

Management of Overdose The treatment of overdose primarily involves supportive care and symptomatic management. Healthcare professionals should monitor the patient closely and provide appropriate interventions based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to take CORASPIRINA 81 mg with a full glass of water to ensure proper swallowing and absorption. It is important to inform patients that CORASPIRINA 81 mg should not be crushed or chewed, as this may affect the medication's efficacy and safety.

Healthcare providers should counsel patients to disclose any history of gastrointestinal bleeding or ulcers, as this may influence the appropriateness of CORASPIRINA 81 mg for their treatment. Additionally, patients should be advised to avoid taking CORASPIRINA 81 mg in conjunction with other NSAIDs or aspirin-containing products unless specifically directed by their healthcare provider, to minimize the risk of adverse effects.

Patients must be informed about the potential risk of bleeding associated with CORASPIRINA 81 mg. They should be instructed to seek medical attention if they experience any unusual bruising or bleeding, as these may be signs of serious complications.

Finally, it is crucial to advise patients to keep CORASPIRINA 81 mg out of reach of children. In the event of accidental ingestion, patients should be instructed to seek immediate medical help to ensure safety.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F).

To ensure the integrity of the product, it must be protected from light and the container should be kept tightly closed at all times. Proper adherence to these storage and handling guidelines is crucial for maintaining the product's efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Coraspirina 81 mg Tabletas Con Cubierta Enterica, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Coraspirina 81 mg Tabletas Con Cubierta Enterica, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.